Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Raidoo, R. Ramsaroop, S. Naidoo, K. Bhoola (1996)
Regional distribution of tissue kallikrein in the human brain.Immunopharmacology, 32 1-3
T. Christopher, X. Ma, T. Gauthier, A. Lefer (1994)
Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock.The American journal of physiology, 266 3 Pt 2
K. Wirth, G. Breipohl, J. Stechl, J. Knolle, S. Henke, B. Scholkens (1991)
DesArg9D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin (desArg10-[Hoe140]) is a bradykinin B1 receptor antagonistEuropean Journal of Pharmacology, 205
P. Chan, Guo-Yuan Yang, Sylvia Chen, E. Carlson, C. Epstein (1991)
Cold‐induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn‐Superoxide dismutaseAnnals of Neurology, 29
E. Whalley, M. Wahl (1983)
Analysis of bradykinin receptor mediating relaxation of cat cerebral arteries in vivo and in vitroNaunyn-Schmiedeberg's Archives of Pharmacology, 323
M. Schwaninger, Svea Sallmann, N. Petersen, Armin Schneider, Simone Prinz, T. Libermann, M. Spranger (1999)
Bradykinin Induces Interleukin‐6 Expression in Astrocytes Through Activation of Nuclear Factor‐κBJournal of Neurochemistry, 73
E. Chen, D. Emerich, R. Bartus, J. Kordower (2000)
B2 bradykinin receptor immunoreactivity in rat brainJournal of Comparative Neurology, 427
S. Böckmann, I. Paegelow (2000)
Kinins and kinin receptors: importance for the activation of leukocytesJournal of Leukocyte Biology, 68
PRUNEAU PRUNEAU, PAQUET PAQUET, LUCCARINI LUCCARINI, DEFRENE DEFRENE, FOUCHET FOUCHET, FRANCK FRANCK, LOILLIER LOILLIER, ROBERT ROBERT (2000)
LF 16‐0687, a new potent non‐peptide bradykinin B2 receptor antagonistRestor. Neural. Neurosci., 16
F. Hock, K. Wirth, U. Albus, W. Linz, H. Gerhards, G. Wiemer, S. Henke, G. Breipohl, W. König, J. Knolle, B. Schölkens (1991)
Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studiesBritish Journal of Pharmacology, 102
L. Makevnina, I. Lomova, Zubkov YuN, V. Semenyutin (1994)
Kininogen consumption in cerebral circulation of humans during brain ischemia and postischemic reperfusion.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 27 8
D. Regoli, S. Allogho, A. Rizzi, Fernand Gobeil (1998)
Bradykinin receptors and their antagonists.European journal of pharmacology, 348 1
Journal of Cerebral Blood Flow and Metabolism Letters to the Editor
S. Wagner, P. Kalb, Martina Lukosava, U. Hilgenfeldt, M. Schwaninger (2002)
Activation of the tissue kallikrein–kinin system in strokeJournal of the Neurological Sciences, 202
E. Gustafson, A. Schmaier, Y. Wachtfogel, N. Kaufman, U. Kucich, R. Colman (1989)
Human neutrophils contain and bind high molecular weight kininogen.The Journal of clinical investigation, 84 1
(1990)
Initiation of eicosanoid and free radical formation following brain injury: the role of the kallikrein –kinin system
K. Bhoola, R. Ramsaroop, J. Plendl, B. Cassim, Zodwa Dlamini, S. Naicker (2001)
Kallikrein and Kinin Receptor Expression in Inflammation and Cancer, 382
K. Bhoola (1996)
Translocation of the neutrophil kinin moiety and changes in the regulation of kinin receptors in inflammation.Immunopharmacology, 33 1-3
V. Carl, E. Moore, F. Moore, E. Whalley (1996)
Involvement of bradykinin B1 and B2 receptors in human PMN elastase release and increase in endothelial cell monolayer permeability.Immunopharmacology, 33 1-3
J. Bederson, L. Pitts, S. Germano, M. Nishimura, R. Davis, H. Bartkowski (1986)
Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 17 6
C. Sobey, D. Heistad, F. Faraci (1997)
Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels.Stroke, 28 11
T. Kamiya, Y. Katayama, F. Kashiwagi, A. Terashi (1993)
The Role of Bradykinin in Mediating Ischemic Brain Edema in RatsStroke, 24
Su-Lan Liao, Wenyin Chen, S. Raung, Jon‐Son Kuo, Chun-Jung Chen (2001)
Association of immune responses and ischemic brain infarction in ratNeuroreport, 12
P. Kochanek, J. Hallenbeck (1992)
Polymorphonuclear Leukocytes and Monocytes/Macrophages in the Pathogenesis of Cerebral Ischemia and StrokeStroke, 23
P. Francel (1992)
Bradykinin and neuronal injury.Journal of neurotrauma, 9 Suppl 1
K. Maier-Hauff, A. Baethmann, M. Lange, L. Schürer, A. Unterberg (1984)
The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue.Journal of neurosurgery, 61 1
J. Lehmberg, J. Beck, A. Baethmann, E. Uhl (2000)
Influence of the Bradykinin Bl/B2-Receptor-Antagonist B 9430 on the Cerebral Microcirculation and Outcome of Gerbils from Global Cerebral IschemiaActa Neurochirurgica, 76
K. Satoh, H. Yoshida, Tada-Atsu Imalzumi, M. Koyama, S. Takamatsu (1995)
Production of Platelet-Activating Factor by Porcine Brain Microvascular Endothelial Cells in CultureThrombosis and Haemostasis, 74
Y. Matsuo, T. Kihara, M. Ikeda, M. Ninomiya, H. Onodera, K. Kogure (1995)
Role of Neutrophils in Radical Production during Ischemia and Reperfusion of the Rat Brain: Effect of Neutrophil Depletion on Extracellular Ascorbyl Radical FormationJournal of Cerebral Blood Flow & Metabolism, 15
W. Rosenblum (1987)
Hydroxyl Radical Mediates the Endothelium‐Dependent Relaxation Produced by Bradykinin in Mouse Cerebral ArteriolesCirculation Research, 61
Z. Rózsa, J. Russell, J. Salter, D. Granger (1998)
Bradykinin mediates P-selectin expression in rat gastrointestinal microvasculatureGastroenterology, 114
S. Zausinger, D. Lumenta, D. Pruneau, R. Schmid-Elsaesser, N. Plesnila, Alexander Baethmann (2002)
Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemiaBrain Research, 950
N. Plesnila, J. Schulz, M. Stoffel, J. Eriskat, D. Pruneau, A. Baethmann (2001)
Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats.Journal of neurotrauma, 18 10
Y. Ikeda, M. Wang, S. Nakazawa (1994)
Simple quantitative evaluation of blood-brain barrier disruption in vasogenic brain edema.Acta neurochirurgica. Supplementum, 60
C. Görlach, M. Wahl (1996)
Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxidePeptides, 17
Rune Sörnäs, Haldo Östlund, Ragnar Müller (1972)
Cerebrospinal fluid cytology after stroke.Archives of neurology, 26 6
GOLANOV GOLANOV, REIS REIS (1995)
Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in ratJ. Cereb. Blood Flow Metab., 15
K. Wirth, F. Hock, U. Albus, W. Linz, H. Alpermann, H. Anagnostopoulos, S. Henke, G. Breipohl, W. Konig, J. Knolle, B. Scholkens (1991)
Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studiesBritish Journal of Pharmacology, 102
M. Rydh-Rinder, N. Kerekes, M. Svensson, T. Hökfelt (2001)
Glutamate release from adult primary sensory neurons in culture is modulated by growth factorsRegulatory Peptides, 102
S. Hatashita, J. Hoff, S. Salamat (1988)
Ischemic Brain Edema and the Osmotic Gradient between Blood and BrainJournal of Cerebral Blood Flow & Metabolism, 8
D. Raidoo, K. Bhoola (1997)
Kinin receptors on human neuronesJournal of Neuroimmunology, 77
M. Spiegel-Adolf (1965)
Cerebrospinal fluid.Progress in neurology and psychiatry, 20
A. Unterberg, C. Dautermann, A. Baethmann, W. Müller-Esterl (1986)
The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling.Journal of neurosurgery, 64 2
F. Marceau (1995)
Kinin B1 receptors: a review.Immunopharmacology, 30 1
J. Relton, V. Beckey, W. Hanson, E. Whalley (1997)
CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion.Stroke, 28 7
J. Cheronis, E. Whalley, K. Nguyen, S. Eubanks, L. Allen, M. Duggan, S. Loy, K. Bonham, J. Blodgett (1992)
A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.Journal of medicinal chemistry, 35 9
J. Stover, N. Dohse, A. Unterberg (2000)
Bradykinin 2 receptor antagonist LF 16-0687Ms reduces posttraumatic brain edema.Acta neurochirurgica. Supplement, 76
S. Costa, R. Moreno, L. Esquisatto, L. Juliano, S. Brain, G. Nucci, E. Antunes (2002)
Role of kinins and sensory neurons in the rat pleural leukocyte migration induced by Phoneutria nigriventer spider venomNeuroscience Letters, 318
F. Cunha, S. Poole, B. Lorenzetti, S. Ferreira (1992)
The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesiaBritish Journal of Pharmacology, 107
K. Walker, M. Perkins, A. Dray (1995)
Kinins and kinin receptors in the nervous systemNeurochemistry International, 26
K. Bhoola, C. Figueroa, K. Worthy (1992)
Bioregulation of kinins: kallikreins, kininogens, and kininases.Pharmacological reviews, 44 1
V. Parpura, T. Basarsky, Fang Liu, K. Jeftinija, S. Jeftinija, P. Haydon (1994)
Glutamate-mediated astrocyte–neuron signallingNature, 369
(2000)
Neuro - protective effect of LF 16 - 0687 Ms , a bradykinin B 2 receptor antagonist , on a model of traumatic brain injury in mice
Zvonimir KatušiOV0627, J. Milde, F. Cosentino, Bora Mitrovi&OV0627; (1993)
Subarachnoid Hemorrhage and Endothelial L‐Arginine Pathway in Small Brain Stem Arteries in DogsStroke, 24
M. Haasemann, C. Figueroa, L. Henderson, S. Grigoriev, S. Alla, C. Gonzalez, I. Dunia, J. Hoebeke, K. Jarnagin, J. Cartaud (1994)
Distribution of bradykinin B2 receptors in target cells of kinin action. Visualization of the receptor protein in A431 cells, neutrophils and kidney sections.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 27 8
J. Kaplanski, D. Pruneau, I. Asa, A. Artru, Abeb Azez, Y. Ivashkova, Z. Rudich, Y. Shapira (2002)
LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats.Journal of neurotrauma, 19 8
S. Shigematsu, S. Ishida, D. Gute, R. Korthuis (1999)
Concentration-dependent effects of bradykinin on leukocyte recruitment and venular hemodynamics in rat mesentery.American journal of physiology. Heart and circulatory physiology, 277 1
Ding-Zhou Li, C. Marchand-Verrecchia, N. Croci, M. Plotkine, I. Margaill (2002)
L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice.European journal of pharmacology, 457 2-3
Didier Pruneau, J. Paquet, J. Luccarini, E. Defrêne, Chantal Fouchet, R. Franck, B. Loillier, C. Robert, P. Bélichard, Hervé Duclos, B. Cremers, P. Dodey (1999)
Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist.Immunopharmacology, 43 2-3
S. Jeftinija, K. Jeftinija, G. Stefanović, Fang Liu (1996)
Neuroligand‐Evoked Calcium‐Dependent Release of Excitatory Amino Acids from Cultured AstrocytesJournal of Neurochemistry, 66
H. Kamii, H. Kinouchi, F. Sharp, C. Epstein, S. Sagar, P. Chan (1994)
Expression of c-fos mRNA after a mild focal cerebral ischemia in SOD-1 transgenic miceBrain Research, 662
E. Hall (1985)
High-dose glucocorticoid treatment improves neurological recovery in head-injured mice.Journal of neurosurgery, 62 6
Á. Gecse, Z. Mezei, G. Telegdy (1989)
The effect of bradykinin and its fragments on the arachidonate cascade of brain microvessels.Advances in experimental medicine and biology, 247A
LEHMBERG LEHMBERG, BECK BECK, BAETHMANN BAETHMANN, UHL UHL (1998)
Influence of the bradykinin B2‐receptor‐antagonist CP‐0597 on the cerebral microcirculation and outcome on global cerebral ischemiaCerebrovasc. Dis., 8
E. Ellis, J. Chao, M. Heizer (1989)
Brain kininogen following experimental brain injury: evidence for a secondary event.Journal of neurosurgery, 71 3
C. Görlach, Tibor Hortobágyi, S. Hortobágyi, Zoltán Benyó, J. Relton, Eric Whalley, Michael Wahll (2001)
Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury.Journal of neurotrauma, 18 8
J. Schulz, N. Plesnila, J. Eriskat, M. Stoffel, D. Pruneau, A. Baethmann (2000)
LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats.Acta neurochirurgica. Supplement, 76
T. McIntyre, G. Zimmerman, K. Satoh, S. Prescott (1985)
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.The Journal of clinical investigation, 76 1
E. Hösli, L. Hösli (1993)
Autoradiographic localization of binding sites for neuropeptide Y and bradykinin on astrocytes.Neuroreport, 4 2
F. Cunha, S. Poole, B. Lorenzetti, S. Ferreira (1992)
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia.British journal of pharmacology, 107 3
A. Unterberg, A. Baethmann (1984)
The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma.Journal of neurosurgery, 61 1
D. Pruneau, I. Chorny, V. Benkovitz, A. Artru, L. Roitblat, Y. Shapira (1999)
Effect of LF 16-0687MS, a new nonpeptide bradykinin B2 receptor antagonist, in a rat model of closed head trauma.Journal of neurotrauma, 16 11
F. Barone, L. Hillegass, W. Price, R. White, E. Lee, G. Feuerstein, H. Sarau, R. Clark, D. Griswold (1991)
Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verificationJournal of Neuroscience Research, 29
K. Kizuki, Tomohiko Suzuki, M. Kudo, T. Noguchi (1994)
Immunohistochemical demonstration of tissue kallikrein in the neurons of rat brainBrain Research, 634
D. Raidoo, K. Bhoola (1998)
Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue.Pharmacology & therapeutics, 79 2
M. Rachinsky, D. Pruneau, A. Artru, V. Kapuler, A. Alonchin, Y. Smolanezki, Y. Shapira (2001)
The importance of kinin antagonist treatment timing in closed head trauma.The Journal of trauma, 51 5
Wolfgang Walz (1999)
Cerebral ischemia : molecular and cellular pathophysiology
A. Unterberg, M. Wahl, A. Baethmann (1984)
Effects of Bradykinin on Permeability and Diameter of Pial Vessels In vivoJournal of Cerebral Blood Flow & Metabolism, 4
Makevnina Lg, Lomova Ip, Zubkov YuN, S. Vb (1994)
Kininogen consumption in cerebral circulation of humans during brain ischemia and postischemic reperfusion.Brazilian Journal of Medical and Biological Research, 27
M. Félétou, M. Germain, C. Thurieau, J. Fauchère, E. Canet (1994)
Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different speciesBritish Journal of Pharmacology, 112
M. Wahl, E. Whalley, A. Unterberg, L. Schilling, Andrew Parsons, Alexander Baethmann, A. Young (1996)
Vasomotor and permeability effects of bradykinin in the cerebral microcirculation.Immunopharmacology, 33 1-3
Bradykinin promotes neuronal damage and brain edema through the activation of the B2 receptor. The neuroprotective effect of LF 16‐0687 Ms, a B2 receptor antagonist, has been described when given prior to induction of transient focal cerebral ischemia in rat, but there are no data regarding the consequence of a treatment when given after injury. Therefore, in a murine model of transient middle cerebral artery occlusion (MCAO), we evaluated the effect of LF 16‐0687 Ms given prior to and/or after the onset of ischemia on neurological deficit, infarct volume and inflammatory responses including cerebral edema, blood–brain barrier (BBB) disruption and neutrophil accumulation. LF 16‐0687 Ms (1, 2 and 4 mg kg−1) administered 0.5 h before and, 1.25 and 6 h after MCAO, decreased the infarct volume by a maximum of 33% and significantly improved the neurological recovery. When given at 0.25 and 6.25 h after MCAO, LF 16‐0687 Ms (1.5, 3 and 6 mg kg−1) decreased the infarct volume by a maximum of 25% and improved the neurological score. Post‐treatment with LF 16‐0687 Ms (1.5 mg kg−1) significantly decreased brain edema (−28%), BBB disruption (−60%) and neutrophil accumulation (−65%) induced by ischemia. Physiological parameters were not modified by LF 16‐0687 Ms. These data emphasize the role of bradykinin B2 receptor in the development of infarct lesion, neurological deficit and inflammatory responses resulting from transient focal cerebral ischemia. Therefore, B2 receptor antagonist might represent a new therapeutic approach in the pharmacological treatment of stroke. British Journal of Pharmacology (2003) 139, 1539–1547. doi:10.1038/sj.bjp.0705385
British Journal of Pharmacology – Wiley
Published: Aug 1, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.